The document discusses several numbers related to inclusion, dosage regimen, length of research time, and another number. Specifically, it mentions number 9 which relates to inclusion, number 14 regarding dosage regimen, and number 15 about the length of the research or study time period. Another number, 30, is listed without additional context.
The document discusses several numbers related to inclusion, dosage regimen, length of research time, and another number. Specifically, it mentions number 9 which relates to inclusion, number 14 regarding dosage regimen, and number 15 about the length of the research or study time period. Another number, 30, is listed without additional context.
The document discusses several numbers related to inclusion, dosage regimen, length of research time, and another number. Specifically, it mentions number 9 which relates to inclusion, number 14 regarding dosage regimen, and number 15 about the length of the research or study time period. Another number, 30, is listed without additional context.
The document discusses several numbers related to inclusion, dosage regimen, length of research time, and another number. Specifically, it mentions number 9 which relates to inclusion, number 14 regarding dosage regimen, and number 15 about the length of the research or study time period. Another number, 30, is listed without additional context.